LinkedIn
Singapore
Expand search
Jobs
People
Learning
Dismiss
Dismiss
Dismiss
Dismiss
Dismiss
Join now
Sign in
Skip to main content
DataM Intelligence Newsletters
Stay Informed, Stay Ahead: Your Source for Market Updates and Trends!
Newsletter
Published weekly
Join to Subscribe
Report this newsletter
Created by
DataM Intelligence
Editions
Report this post
Atsena Therapeutics Advances Gene Therapy Innovation with FDA RMAT Designation
DataM Intelligence on LinkedIn
Like
Comment
Share
Report this post
Valneva’s Chikungunya Vaccine Makes History with First-Ever Approval in Endemic…
DataM Intelligence on LinkedIn
Like
Comment
Share
Report this post
FDA Approves Self-Injection Option for VYVGART Hytrulo in gMG and CIDP
DataM Intelligence on LinkedIn
Like
Comment
Share
Report this post
Atea Pharmaceuticals Initiates Phase III Trial for Next-Generation Oral HCV…
DataM Intelligence on LinkedIn
Like
Comment
Share
Report this post
European Commission Approves Subcutaneous RYBREVANT® (amivantamab) for Advanced…
DataM Intelligence on LinkedIn
Like
Comment
Share
More from this author
Opthea Announces Discontinuation of Wet AMD Trials Following Phase III Setbacks
2w
Innovent Receives NMPA Breakthrough Therapy Designation for IBI363 in Melanoma
3w
UK MHRA Accepts Application for Proposed Biosimilar to Xolair®
3w